Plexus Corp (PLXS) · Nov 19, 2026 · Exec change
Chair succession — Schrock succeeds Foate after the 2027 annual meeting
Plexus announced a 2027 board-chair transition from Dean Foate to lead director Michael Schrock, alongside a smaller nine-member board.
Plexus is a global manufacturing partner focused on complex products in Aerospace/Defense, Healthcare/Life Sciences, and Industrial markets, with recent growth built around new program launches and market-share gains.
The transition is orderly, not an operating setback. Chair Dean Foate will leave the board after the 2027 annual meeting, while current lead director Michael Schrock is designated to succeed him; the filing explicitly says Foate’s decision is personal and not tied to any disagreement. 〔0〕
Continuity limits the business impact. Schrock is already a board member and lead director, so this is an internal handoff rather than a change in strategic control. The reduction from ten directors to nine is modest housekeeping, but it also removes an experienced chair from the board and makes shareholder reelection a condition of the succession. 〔1〕
Bottom line: This is a credible, low-disruption governance transition rather than a change to Plexus’s operating story. It matters mainly as a leadership handoff, with continuity outweighing the loss of the current chair.
2027 annual meeting and Schrock reelection
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!